Octagos Selected as a Cardiac Remote Monitoring Company in Microsoft for Startups Pegasus Program

HOUSTON, July 17, 2025 /PRNewswire/ -- Octagos, one of the fastest-growing remote cardiac monitoring platforms, today announced its selection for the Microsoft for Startups Pegasus Program - an elite, invite-only initiative for high-growth startups advancing innovation in AI, healthcare, and cybersecurity.

Octagos is one of the only companies in the cardiac remote monitoring industry to be chosen for the program, gaining access to Microsoft's global enterprise ecosystem, go-to-market experts, and Microsoft Azure's secure, scalable, AI-optimized cloud infrastructure. The Pegasus collaboration is the latest in a series of bold strides for Octagos, cementing its place as an industry category-defining leader.

Since 2020, Octagos has been on a relentless growth trajectory. Built by electrophysiology experts and trusted by over 300 clinical locations, the company has:

• Processed over 1 billion transmission report pages – turning vast, fragmented data into timely, AI-enabled clinical reports enhanced by IBHRE-certified clinical specialists.

• Completed 200+ bi-directional EHR integrations, with full interoperability achieved in under four weeks on average.

• Delivered over 65% reduction in unnecessary transmissions at active clinics.

"Being selected for the Microsoft for Startups Pegasus Program is a validation of our unique solution, AI-driven efficiency, and proven clinical impact," said Dr. Shanti Bansal, founder and CEO of Octagos. "This collaboration accelerates our mission to transform remote cardiac care and enhance the efficiency and quality of patient monitoring."

"Octagos is exactly the kind of innovative company the Microsoft for Startups Pegasus Program was built to support," said Sally Ann Frank, Global Lead – Health & Life Sciences, Microsoft for Startups. "Their AI-driven solution empowers providers with timely, actionable insights, advancing cardiac care and enabling faster, more effective interventions. We're proud to support their next stage of growth."

Octagos' recent momentum includes the launch of the OctaLink Clinic Mobile App, real-time support for ambulatory monitors, heart failure diagnostics, and RPM systems, and deep investments in AI-enhanced clinical reporting and engineering infrastructure.

To support this scale, the company has significantly expanded its executive team with key hires across commercial, AI, product, and customer success functions. It also secured institutional investment from Morgan Stanley, further powering its national expansion and technology roadmap.

Participation in the Pegasus Program marks the next chapter in Octagos' story of transformative growth. By unifying cardiac data, reducing clinical burden, and elevating care, Octagos continues to shape the future of cardiac remote monitoring.

About Octagos
Octagos is redefining remote cardiac monitoring with AI-powered automation, seamless EHR integrations, and industry-leading accuracy. Our advanced Atlas AI technology delivers the most precise clinical reports, significantly reducing workload while enhancing patient care. With the fastest bi-directional integrations in the industry, clinics gain real-time access to critical data without extra costs or delays. Octagos' automation eliminates non-billable noise, streamlines workflows, and ensures every alert matters. Backed by cost-effective, contract-flexible solutions and secure data migration, we empower clinics to operate efficiently without compromise.

Learn more at www.octagos.com.

SOURCE Octagos Health, Inc.